Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phototox: Photosensitizing Potential of Common Medicines
NCT06710600Completed
- Sponsor
- Medical University of Vienna
- Start
- Sep 2022
- Primary completion
- Apr 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of diclofenac, voriconazole, hydrochlorothiazide, pantoprazole, amiodarone and 5 more in pain, fungal infection, hypertension (HTN) and 4 more (2 arms), sponsored by Medical University of Vienna. Primary endpoint: Minimal Erythema Dose at 24 hours. Started Sep 2022; status: completed.
02
Drugs
diclofenacvoriconazolehydrochlorothiazidepantoprazoleamiodarone
03
Conditions
painfungal infectionhypertension (HTN)gastroesophageal reflux disease (GERD)arrhythmia
Beyond the preview
Go deeper on NCT06710600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06710600.